BrightPath Biotherapeutics Co., Ltd.
Developing novel cancer immunotherapies, including peptide vaccines and iPS-NKT cell therapies.
4594 | T
Overview
Corporate Details
- ISIN(s):
- JP3274140007
- LEI:
- Country:
- Japan
- Address:
- 川崎市川崎区殿町三丁目２５番２２号
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
BrightPath Biotherapeutics is a clinical-stage biopharmaceutical company specializing in the development of novel cancer immunotherapies. The company's pipeline encompasses multiple platforms, including cancer peptide vaccines, immuno-modulators, and advanced cell therapies. A primary focus is its proprietary iPS-NKT platform, a novel allogeneic cell therapy that uses natural killer T-cells (NKT cells) derived from induced pluripotent stem cells (iPSCs) for cancer treatment. This technology enables the large-scale, homogeneous production of NKT cells, which are naturally rare. The company, formerly known as GreenPeptide, also develops peptide vaccines like GRN-1201, which has progressed to clinical trials. Its business model covers drug discovery, research, and early-phase clinical development.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-06-20 09:01 |
Post-Annual General Meeting Information
臨時報告書
|
Japanese | 22.8 KB | ||
| 2025-06-19 08:36 |
Registration Form
確認書
|
Japanese | 8.9 KB | ||
| 2025-06-19 08:32 |
Governance Information
内部統制報告書－第22期(2024/04/01－2025/03/31)
|
Japanese | 23.4 KB | ||
| 2025-06-19 08:25 |
Registration Form
有価証券報告書－第22期(2024/04/01－2025/03/31)
|
Japanese | 933.5 KB | ||
| 2024-11-08 07:35 |
Interim Report
確認書
|
Japanese | 9.0 KB | ||
| 2024-11-08 07:34 |
Interim Report
半期報告書－第22期(2024/04/01－2025/03/31)
|
Japanese | 224.9 KB | ||
| 2024-06-21 09:07 |
Regulatory News Service
訂正有価証券届出書（組込方式）
|
Japanese | 254.0 KB | ||
| 2024-06-21 08:34 |
Regulatory News Service
内部統制報告書－第21期(2023/04/01－2024/03/31)
|
Japanese | 23.2 KB | ||
| 2024-06-21 08:33 |
Registration Form
確認書
|
Japanese | 9.0 KB | ||
| 2024-06-21 08:32 |
Annual Report
有価証券報告書－第21期(2023/04/01－2024/03/31)
|
Japanese | 990.5 KB | ||
| 2024-06-19 08:00 |
Registration Form
有価証券届出書（組込方式）
|
Japanese | 513.9 KB | ||
| 2024-02-09 07:12 |
Report Publication Announcement
確認書
|
Japanese | 9.1 KB | ||
| 2024-02-09 07:11 |
Quarterly Report
四半期報告書－第21期第3四半期(2023/10/01－2023/12/31)
|
Japanese | 195.3 KB | ||
| 2023-11-15 07:27 |
Registration Form
訂正有価証券届出書（組込方式）
|
Japanese | 183.0 KB | ||
| 2023-11-14 07:56 |
Registration Form
有価証券届出書（組込方式）
|
Japanese | 332.0 KB |
Automate Your Workflow. Get a real-time feed of all BrightPath Biotherapeutics Co., Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for BrightPath Biotherapeutics Co., Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for BrightPath Biotherapeutics Co., Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
